Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hauser

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Journal of Neurovirology|June 19, 2004
Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GIndrapal N Singh, Robin J Goody, Celeste Dean, et al.
Neurobiology of Disease|February 5, 2016
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrainYun K Hahn, Jason J Paris, Aron H Lichtman, et al.
Neuroscience Letters|September 7, 2019
Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microgliaSulay H Patel, Omnia A Ismaiel, William R Mylott, et al.
ASN Neuro|March 9, 2023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal GangliaMichael Ohene-Nyako, Sara R Nass, Hope T Richard, et al.
European Journal of Pain (London, England)|June 14, 2020
Conditional expression of HIV-1 tat in the mouse alters the onset and progression of tonic, inflammatory and neuropathic hypersensitivity in a sex-dependent mannerDeniz Bagdas, Jason J Paris, Moriah Carper, et al.
ASN Neuro|January 13, 2025
Sex Affects Cognitive Outcomes in HIV-1 Tat Transgenic Mice: Role of CCR5Chloe A Simons, Sarah Kim, Yun K Hahn, et al.
Neurotoxicity Research|November 2, 2005
Molecular targets of opiate drug abuse in neuroAIDSK F Hauser, N El-Hage, S Buch, et al.
Glia|August 30, 2008
HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphologyKurt F Hauser, Yun Kyung Hahn, Valeriya V Adjan, et al.
Scientific Reports|August 12, 2017
Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with agingAlex M Dickens, Seung Wan Yoo, Alfred C Chin, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function <i>In Vitro</i>Sulay Patel, Crystal R Leibrand, Preetha Palasuberniam, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Journal of Neurovirology|June 19, 2004
Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GIndrapal N Singh, Robin J Goody, Celeste Dean, et al.
Neurobiology of Disease|February 5, 2016
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrainYun K Hahn, Jason J Paris, Aron H Lichtman, et al.
Neuroscience Letters|September 7, 2019
Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microgliaSulay H Patel, Omnia A Ismaiel, William R Mylott, et al.
ASN Neuro|March 9, 2023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal GangliaMichael Ohene-Nyako, Sara R Nass, Hope T Richard, et al.
European Journal of Pain (London, England)|June 14, 2020
Conditional expression of HIV-1 tat in the mouse alters the onset and progression of tonic, inflammatory and neuropathic hypersensitivity in a sex-dependent mannerDeniz Bagdas, Jason J Paris, Moriah Carper, et al.
ASN Neuro|January 13, 2025
Sex Affects Cognitive Outcomes in HIV-1 Tat Transgenic Mice: Role of CCR5Chloe A Simons, Sarah Kim, Yun K Hahn, et al.
Neurotoxicity Research|November 2, 2005
Molecular targets of opiate drug abuse in neuroAIDSK F Hauser, N El-Hage, S Buch, et al.
Glia|August 30, 2008
HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphologyKurt F Hauser, Yun Kyung Hahn, Valeriya V Adjan, et al.
Scientific Reports|August 12, 2017
Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with agingAlex M Dickens, Seung Wan Yoo, Alfred C Chin, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function <i>In Vitro</i>Sulay Patel, Crystal R Leibrand, Preetha Palasuberniam, et al.
Pageof 25